Stay updated on NasoVAX in Early COVID-19 Clinical Trial
Sign up to get notified when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.

Latest updates to the NasoVAX in Early COVID-19 Clinical Trial page
- Check6 days agoChange DetectedThe site revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new Revision: v3.7.0 tag appears on the page, marking the current revision level of the study record on ClinicalTrials.gov. This is a metadata update and does not reflect substantive changes to the study data, outcomes, eligibility criteria, or sites.SummaryDifference18%

- Check48 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a minor site update. This change does not modify any study details or visible content.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor site update.SummaryDifference0.1%

- Check83 days agoChange DetectedThe Study Record revision tag was updated from v3.6.3 to v3.6.4, indicating a maintenance-level update to the page's metadata rather than a substantive change to the study details.SummaryDifference0.1%

- Check105 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, representing a minor update to the study record documentation.SummaryDifference0.1%

Stay in the know with updates to NasoVAX in Early COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.